Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies
- PMID: 32446652
- PMCID: PMC7235598
- DOI: 10.1016/j.sapharm.2020.05.017
Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies
Abstract
Coronavirus disease 2019 (COVID-19) arising from Wuhan, China, is currently outbreaking worldwide. The World Health Organization (WHO) has declared COVID-19 to be a global pandemic. COVID-19 could cause a wide range of symptoms ranging from self-limiting fever, sore throat, and cough to more severe symptoms that could lead to acute respiratory distress syndrome. As a result of the lockdown and increased demand, drug shortages could become a growing global issue. This article aims to shed light on the potential impact of drug shortages as a result of this pandemic on patient outcomes and the role of pharmacists and pharmacy policymakers in alleviating this emerging problem.
Keywords: COVID-19; Coronavirus; Drug shortage; Pandemic; Pharmacist; Policymaker.
Copyright © 2020. Published by Elsevier Inc.
Conflict of interest statement
Authors have no competing interests to declare.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
